HIV疫苗-话题@MedSci

#HIV疫苗#

35篇内容 | 2293人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1479686, encodeId=58e714e96862a, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=HIV疫苗将在近几年问世，从源头解决感染问题, objectType=article, longId=88736, objectId=c49488e3633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c49488e3633, replyNumber=0, likeNumber=127, createdTime=2017-02-15, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c49488e3633, moduleTitle=HIV疫苗将在近几年问世，从源头解决感染问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c49488e3633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479685, encodeId=800414e968521, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=革命性的HIV疫苗将于明年进行第二阶段临床试验, objectType=article, longId=84466, objectId=4d3384466b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d3384466b4, replyNumber=0, likeNumber=84, createdTime=2016-12-17, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d3384466b4, moduleTitle=革命性的HIV疫苗将于明年进行第二阶段临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d3384466b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479684, encodeId=59f414e9684f2, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Retrovirology：灭活的全HIV疫苗SAV001可引发抗HIV免疫应答，安全性良好, objectType=article, longId=83615, objectId=b42183615f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b42183615f4, replyNumber=0, likeNumber=83, createdTime=2016-12-07, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b42183615f4, moduleTitle=Retrovirology：灭活的全HIV疫苗SAV001可引发抗HIV免疫应答，安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b42183615f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479683, encodeId=3e7614e968339, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Nat Med：广泛中和抗体为HIV疫苗开发铺平道路, objectType=article, longId=80164, objectId=bdb78016436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdb78016436, replyNumber=0, likeNumber=93, createdTime=2016-10-17, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdb78016436, moduleTitle=Nat Med：广泛中和抗体为HIV疫苗开发铺平道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdb78016436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479682, encodeId=3cd714e96828f, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=JAMA：HIV疫苗开发或需另辟蹊径, objectType=article, longId=72829, objectId=40dae282992, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40dae282992, replyNumber=0, likeNumber=89, createdTime=2016-07-16, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40dae282992, moduleTitle=JAMA：HIV疫苗开发或需另辟蹊径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40dae282992)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479681, encodeId=b47614e96811d, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Nat Med：重磅！研究再次肯定HIV疫苗RV144的效用, objectType=article, longId=72622, objectId=f059e26222f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f059e26222f, replyNumber=0, likeNumber=70, createdTime=2016-07-14, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f059e26222f, moduleTitle=Nat Med：重磅！研究再次肯定HIV疫苗RV144的效用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f059e26222f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479680, encodeId=1e8b14e968026, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Nature：抗体防御艾滋病毒长达6个月，有望接档HIV疫苗的空缺, objectType=article, longId=67411, objectId=ee1a6e41115, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee1a6e41115, replyNumber=0, likeNumber=95, createdTime=2016-05-05, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee1a6e41115, moduleTitle=Nature：抗体防御艾滋病毒长达6个月，有望接档HIV疫苗的空缺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee1a6e41115)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479679, encodeId=173214e9679cf, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=【盘点】HIV疫苗研发进展一览, objectType=article, longId=65618, objectId=6e1b656183a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e1b656183a, replyNumber=0, likeNumber=97, createdTime=2016-03-29, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e1b656183a, moduleTitle=【盘点】HIV疫苗研发进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e1b656183a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479678, encodeId=389014e9678ae, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=STM：研究HIV疫苗的免疫反应为疫苗研发提供线索, objectType=article, longId=57757, objectId=cfc35e757bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfc35e757bc, replyNumber=0, likeNumber=110, createdTime=2015-10-26, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfc35e757bc, moduleTitle=STM：研究HIV疫苗的免疫反应为疫苗研发提供线索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfc35e757bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479677, encodeId=224914e9677f4, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Nature子刊：HIV疫苗开发突破性进展, objectType=article, longId=52837, objectId=bafc5283ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bafc5283ed3, replyNumber=0, likeNumber=94, createdTime=2015-07-05, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bafc5283ed3, moduleTitle=Nature子刊：HIV疫苗开发突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bafc5283ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479676, encodeId=c78214e96765f, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=【盘点】基因疗法&HIV疫苗：治愈艾滋的普罗米修斯之火, objectType=article, longId=47520, objectId=d82d4e52095, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82d4e52095, replyNumber=0, likeNumber=83, createdTime=2015-03-02, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82d4e52095, moduleTitle=【盘点】基因疗法&HIV疫苗：治愈艾滋的普罗米修斯之火, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82d4e52095)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479675, encodeId=be1714e9675e5, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=俄完成3种HIV疫苗研制：进入临床试验阶段, objectType=article, longId=43649, objectId=ee63436498e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee63436498e, replyNumber=0, likeNumber=81, createdTime=2014-12-07, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee63436498e, moduleTitle=俄完成3种HIV疫苗研制：进入临床试验阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee63436498e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479674, encodeId=807e14e9674a9, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=Science：研究者或可构建一种更好的HIV疫苗, objectType=article, longId=34090, objectId=8295340909a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8295340909a, replyNumber=0, likeNumber=111, createdTime=2014-05-06, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8295340909a, moduleTitle=Science：研究者或可构建一种更好的HIV疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8295340909a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479673, encodeId=b0e914e9673f3, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=印度斥巨资研制抗HIV疫苗, objectType=article, longId=9083, objectId=0e1c9083cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e1c9083cc, replyNumber=0, likeNumber=94, createdTime=2012-08-19, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e1c9083cc, moduleTitle=印度斥巨资研制抗HIV疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e1c9083cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479672, encodeId=8dfe14e96721d, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=STM：灵长类动物是研究HIV疫苗B细胞反应的模型, objectType=article, longId=7879, objectId=9036e8793c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9036e8793c, replyNumber=0, likeNumber=87, createdTime=2012-07-18, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9036e8793c, moduleTitle=STM：灵长类动物是研究HIV疫苗B细胞反应的模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9036e8793c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1479671, encodeId=82f514e96719d, content=<a href='/topic/show?id=c22089214a' target=_blank style='color:#2F92EE;'>#HIV疫苗#</a>, objectTitle=GeoVax公司第二代HIV疫苗（HIV/GM-CSF）进入临床试验, objectType=article, longId=6628, objectId=45266628ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45266628ec, replyNumber=0, likeNumber=81, createdTime=2012-05-27, rootId=0, userName=ms306040998833292, userId=5a1c7566889, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45266628ec, moduleTitle=GeoVax公司第二代HIV疫苗（HIV/GM-CSF）进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45266628ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HIV疫苗

2020-05-29

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

HIV疫苗将在近几年问世，从源头解决感染问题

2017-02-15

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

革命性的HIV疫苗将于明年进行第二阶段临床试验

2016-12-17

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Retrovirology：灭活的全HIV疫苗SAV001可引发抗HIV免疫应答，安全性良好

2016-12-07

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Nat Med：广泛中和抗体为HIV疫苗开发铺平道路

2016-10-17

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

JAMA：HIV疫苗开发或需另辟蹊径

2016-07-16

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Nat Med：重磅！研究再次肯定HIV疫苗RV144的效用

2016-07-14

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Nature：抗体防御艾滋病毒长达6个月，有望接档HIV疫苗的空缺

2016-05-05

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

【盘点】HIV疫苗研发进展一览

2016-03-29

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

STM：研究HIV疫苗的免疫反应为疫苗研发提供线索

2015-10-26

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Nature子刊：HIV疫苗开发突破性进展

2015-07-05

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

【盘点】基因疗法&HIV疫苗：治愈艾滋的普罗米修斯之火

2015-03-02

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

俄完成3种HIV疫苗研制：进入临床试验阶段

2014-12-07

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

Science：研究者或可构建一种更好的HIV疫苗

2014-05-06

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

印度斥巨资研制抗HIV疫苗

2012-08-19

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

STM：灵长类动物是研究HIV疫苗B细胞反应的模型

2012-07-18

ms306040998833292 (审核中...)

前往app查看评论内容

#HIV疫苗#

GeoVax公司第二代HIV疫苗（HIV/GM-CSF）进入临床试验

2012-05-27

科室
- - 订阅+
  - 更多科室
工具
服务